Office of Biostatistics, University of Texas Medical Branch, Galveston, Texas, USA.
Department of Preventive Medicine and Population Health, University of Texas Medical Branch, Galveston, Texas, USA.
J Am Geriatr Soc. 2021 Jul;69(7):1916-1924. doi: 10.1111/jgs.17120. Epub 2021 Mar 22.
Potentially inappropriate medication (PIM) use is a risk factor for hospitalization and mortality. However, there were few studies focusing on the impact of provider type on PIM use.
We aimed to estimate the initial and refill PIM prescribing rate for physician visits and nurse practitioner (NP) visits and the impact of provider type on PIM prescribing.
We used 100% Texas Medicare data to define physician visits and NP visits in 2016. The rate of visits with a PIM prescription from the same provider was measured, distinguishing between initial and refill prescription to estimate the PIM rate and adjusted odds ratio (OR) by provider type.
There were 24.1 per 1000 visits with a prescription for a PIM: 9.0 per 1000 visits for an initial PIM and 15.1 per 1000 visits for a refill PIM. A visit to an NP was less likely to result in an initial (OR = 0.74, 95% confidence interval [CI] = 0.70-0.79) or refill (OR = 0.54, 95% CI = 0.51-0.57) PIM. The association of lower odds of receiving a prescription for an initial PIM from an NP was substantially stronger among black enrollees than white enrollees (OR = 0.44, 95%CI = 0.30-0.65 for blacks and OR = 0.73, 95%CI = 0.68-0.78 for white enrollees). The association of an NP provider with lower odds of receiving a PIM refill was more pronounced in older patients and in those with more comorbidities.
NPs prescribed fewer initial PIMs and were less likely to refill a PIM after an outpatient visit than physicians. The lower odds of receiving PIMs during an NP visit varied by age, race/ethnicity, rurality, and number of comorbidities.
潜在不适当药物(PIM)的使用是住院和死亡的风险因素。然而,很少有研究关注提供者类型对 PIM 使用的影响。
我们旨在估计医生就诊和护士从业者(NP)就诊时初始和续方 PIM 处方率,并评估提供者类型对 PIM 处方的影响。
我们使用了 100%的德克萨斯州医疗保险数据,以确定 2016 年的医生就诊和 NP 就诊。测量了来自同一提供者的有 PIM 处方的就诊率,区分初始和续方处方以估计 PIM 率和按提供者类型调整的优势比(OR)。
有 24.1 例/1000 次就诊处方为 PIM:初始 PIM 9.0 例/1000 次就诊,续方 PIM 15.1 例/1000 次就诊。NP 就诊不太可能导致初始(OR=0.74,95%置信区间[CI]为 0.70-0.79)或续方(OR=0.54,95%CI 为 0.51-0.57)PIM。与 NP 就诊相比,黑人参保者接受初始 PIM 处方的可能性较低(OR=0.44,95%CI 为 0.30-0.65),而白人参保者的可能性较低(OR=0.73,95%CI 为 0.68-0.78)。NP 提供者与接受 PIM 续方的可能性较低之间的关联在老年患者和合并症较多的患者中更为明显。
与医生相比,NP 开具的初始 PIM 较少,并且不太可能在门诊就诊后为患者续方 PIM。NP 就诊时接受 PIM 的可能性较低,这取决于年龄、种族/民族、农村/城市、以及合并症的数量。